Abridge is a medical conversation AI startup that offers an audio-based system to record and summarize medical conversations. It was created for everyone, with a mission to help better understand their health conversations, whether at home or in the hospital.

Andes develops an integrated microbial technology to help accelerate crop growth. Its technology is combined with artificial intelligence to develop its seeds while reducing input costs and environmental footprints and helps farmers to boost their agricultural output and income. Andes was founded in 2018 and is headquartered in Alameda, California.

Aperiam Bio partners with enzyme engineers and distributors to create and share stabilized, solubilized, and catalytically optimized proteins. The company was founded in 2021 and is headquartered in Austin, Texas, United States.

Azitra is a clinical-stage medical dermatology company that leverages extensive scientific knowledge about the skin microbiome to discover and develop novel products for the treatment of adverse skin conditions and diseases.The Company’s technology platform, developed in collaboration with scientists at Yale University and the Jackson Laboratory, is based on a proprietary strain of the natural commensal bacteria Staphylococcus epidermidis.

Braid Health is a digital health innovation company that develops an AI-powered diagnostic collaboration platform that improves the speed, quality, and workflow of radiologists and healthcare providers. Braid Health empowers radiologists and healthcare providers to deliver diagnoses for any patient, anywhere.

Bullseye Biosciences is a biotechnology research company based in Cambridge, MA. They specialize in the continuous evolution of biotherapeutics, unlocking the power of protein therapeutics. Their PRANCE platform combines robotics and phage assisted con...

Canaery is building a neural interface for analyzing an object’s scent fingerprint to identify dangerous compounds at places like ports and inspection points without (or in addition to) x-rays or cameras.

Character Therapeutics is a patient-driven therapeutics company that uses genomics, longitudinal clinical and imaging data, machine learning, and novel experimental approaches to identify the molecular drivers of disease progression and develop innovative targeted medicines. Its dedication to patients is reflected in the high standards set to ensure privacy, data security, ethics, scientific rigor, and a meaningful impact on patient health. To enable clinical genomic research, the company collaborates with patients, providers, payers, and scientists to create deeply phenotyped patient cohorts.

Checkerspot is a materials innovation company that designs materials at a molecular level. The company is driven by a mission to use the power of biotechnology to expand the palette of molecular building blocks for high-performance and sustainable materials.

Cirsium Biosciences is democratizing gene therapy through transformative viral vector production methods and systems.

Curie.Bio is a founder-focused seed-stage venture firm combined with an industry-grade therapeutics accelerator focused on one thing: helping entrepreneurial founders launch viable therapeutics companies. Curie.Bio does this by giving founders access to a team of the world’s best drug hunters and drug makers, seed capital, and best-of-breed services - everything a founder needs to get from concept to a compelling quality dataset that enables an awesome Series A financing. In a nutshell, we want founders in control of their own company and focused on their area of expertise and creativity, while we help make the rest happen smoothly.

Cypris Materials is developing a new generation of sustainable color that broadens the color gamut while simplifying manufacturing, application and formulation. Cypris Materials, Inc. has harnessed the transformative power of structural color - a method of producing color that has evolved over millions of years. Cypris Materials' structural coating platform helps industry-leading companies and individuals redefine the capabilities of color. Our polymers, backed by an extensive patent portfolio, unlock exclusive colors and effects that can only be achieved through our paint. Cypris’ materials enable a new paradigm: the first safe and sustainable structural color palette, free of toxic pigments and dyes.